SAGILITY LIMITED has acquired CareSeed, a US-based healthcare analytics company specializing in NCQA-certified HEDIS quality reporting, medical record review, chart abstraction, and regulatory analytics for health plans. The acquisition accelerates Sagility's AI-led quality operations and Medicare Advantage performance transformation.
CareSeed, founded in 2012 and headquartered in Kansas City, Missouri, serves 30 small and mid-sized US health plans with a strong footprint in Medicare Advantage. Its cloud-native platforms, Forecast and Harvest, help health plans improve HEDIS performance, streamline chart abstraction and medical record review workflows, and manage regulatory requirements.
CareSeed reported revenues of $5.1 million in CY25 with EBITDA of $1.6 million at a 31.4% margin. The transaction involves a 100% acquisition of CareSeed, is expected to be EPS accretive, and is slated to close on June 11, 2026.
The acquisition expands Sagility's healthcare quality and Stars capabilities, advancing Sagility's vision of moving health plans beyond retrospective HEDIS reporting toward integrated, member-level quality orchestration. By combining CareSeed's technology with Sagility's healthcare operations, clinical services, and AI-led transformation capabilities, Sagility will deliver an end-to-end quality operations continuum.
The combined offering will support health plans across the full quality lifecycle, from HEDIS abstraction and reporting to prospective gap closure, provider engagement, care coordination, and continuous performance monitoring. The deal strengthens Sagility's position in the mid-market payer segment while expanding opportunities to bring scalable quality and Stars solutions to larger national health plans.
Houlihan Lokey served as exclusive financial advisor to CareSeed on the transaction.
Disclaimer: This article is based on company filings submitted to the Bombay Stock Exchange (BSE) and National Stock Exchange of India (NSE) and is for informational purposes only. It does not constitute investment advice or a recommendation. Investors should conduct their own research and consult a qualified financial advisor before making investment decisions.